Skip to main content
Premium Trial:

Request an Annual Quote

Prometheus Biosciences: Mark Stenhouse

Prometheus Biosciences, a developer of therapeutic and companion diagnostic products for inflammatory bowel disease, has appointed Mark Stenhouse as chief operating officer. Stenhouse previously served as general manager of the screening business at Exact Sciences. He previously spent nearly 30 years at Abbott Laboratories/AbbVie, most recently as vice president of US immunology. He was also vice president and general manager of the gastroenterology franchise, having spent 10 years working in IBD. Stenhouse currently is a member of the board of directors for Phathom Pharmaceuticals.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.